Загрузка...
Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
OBJECTIVE: This study evaluated the association of time in range (TIR) of 70–180 mg/dL (3.9–10 mmol/L) with the development or progression of retinopathy and development of microalbuminuria using the Diabetes Control and Complications Trial (DCCT) data set in order to validate the use of TIR as an o...
Сохранить в:
| Опубликовано в: : | Diabetes Care |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Diabetes Association
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6905478/ https://ncbi.nlm.nih.gov/pubmed/30352896 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc18-1444 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|